Clinical Trial Update: Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance [NA]

View source ↗

Summary

Clinical trial comparing Dotarem (gadoterate meglumine) to Gadovist (gadobutrol) for late gadolinium enhancement in cardiac magnetic resonance, with the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Coronary Artery Disease

Drugs mentioned

• DOTAREM (Gadoterate meglumine)
• Gadovist (gadobutrol)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Coronary Artery Disease, Cardiomyopathy | NA | Status: COMPLETED